OverviewSuggest Edit
The UK’s first dedicated synthetic biology company with a world leading platform of technologies for the rapid engineering and optimisation of novel biological production systems. A spin out of University College London, Synthace is already producing high-value research and development products for the pharmaceutical, agrochemical and fine chemicals industry. Synthace bioengineering is enabled by a tight integration of computational modelling and big data analysis with wet lab experimental design and validation, and novel molecular biology tools. While Synthace bioengineering is broadly applicable across multiple industry sectors, the company is focused towards applications in the production of specialty chemicals.
| Type | Private | |
| Founded | 2011 | |
| HQ | London, GB | Map |
| Website | synthace.com |
Key People/Management at Synthace
Bob Wiederhold
Chairman
Tim Fell
Chief Executive Officer, Director
Christopher Grant Ward
Co-Founder
Susan Shiff
Non-Executive Director
Isabel Fox
Non-Executive Director
Patrick Zhang
Non-Executive Director
Synthace Office Locations
Synthace has offices in London and Cambridge
London, GB (HQ)
195 Wood Ln, Shepherd's Bush
Cambridge, US
101 Main St
Synthace Financials and Metrics
Summary Metrics
Founding Date | 2011 |
Synthace total Funding | $41.8 m |
Synthace latest funding size | $25.60 m |
Time since last funding | 2 years ago |
Synthace investors | Horizons Ventures, Amadeus Capital Partners, Sofinnova Partners, Rainbow Seed Fund, David Lucas, John Anthony Knight, Keith Willey, Michail Eleftheriou, Sami Mikati, Sharaf Yamani, SOSV, White Cloud Capital, Eleven Two Capital, Bioeconomy Capital, Luminous Ventures, Patrick Zhang |
Synthace's latest funding round in December 2018 was reported to be $25.6 m. In total, Synthace has raised $41.8 m
Synthace Revenue
Synthace's revenue was reported to be £581 in FY, 2013
| GBP | |
|---|---|
Revenue (FY, 2013) | 581.0 |
Net income (FY, 2013) | (361.6k) |
EBITDA (FY, 2013) | (356.8k) |
EBIT (FY, 2013) | (361.6k) |
Cash (31-May-2018) | 4.9m |
| GBP | FY, 2012 | FY, 2013 |
|---|---|---|
Revenue | 581.0 | |
Operating expense total | 362.2k | |
EBITDA | (356.8k) | |
EBITDA margin, % | (61413%) |
| GBP | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 |
|---|---|---|---|---|---|---|---|
Cash | 351.4k | 103.4k | 321.7k | 1.5m | 245.0k | 224.3k | 4.9m |
Accounts Receivable | 240.0 | 159.9k | 73.2k | 9.6k | 46.6k | 107.7k | |
Current Assets | 358.1k | 150.1k | 481.6k | 1.6m | 646.8k | 883.2k | 5.8m |
PP&E | 1.6k | 14.8k | 298.8k | 200.5k | 265.6k | 186.8k | 235.7k |
| GBP | FY, 2012 | FY, 2013 |
|---|---|---|
Net Income | (43.1k) | (361.6k) |
| GBP | FY, 2012 |
|---|---|
Financial Leverage | 1 x |
Synthace Cybersecurity Score
Synthace Online and Social Media Presence
1.53k Twitter followers
Synthace has 1.53k Twitter Followers. The number of followers has increased 1.4% month over month and increased 5.5% quarter over quarter
Synthace's Trends
Twitter Engagement Stats for @synthace
1.1k
Tweets
180
Following
1.5k
Followers
32
Tweets last 30 days
1.2
Avg. likes per Tweet
75%
Tweets with engagement
Synthace News and Updates
December 12, 2018
Synthace raises $25.6 million to automate bio labs with software
Synthace, a U.K. startup developing an operating system to automate lab work, announced that it has raised $25.6 million in a Series B round.
September 19, 2017
Synthace reels in $9.6 mln Series A
London-based Synthace, the developer of the Antha operating system for biology, has raised $9.6 million in Series A funding. The investors included White Cloud Capital, Amadeus Capital Partners, Eleven Two Capital, Sofinnova Partners, SOSV and Bioeconomy Capital.
Synthace Blogs
July 06, 2020
Here’s Why You Should Stop Doing Science Like You Were Taught in High School: Part 3
Check out Part 1 and Part 2 of “Here’s Why You Should Stop Doing Science Like You Were Taught in High School”. In this series of blog posts, we challenge the traditional one-factor-at-a-time (OFAT) approach to doing science, which most of us were taught in school and continue to use until now. This…
July 01, 2020
Building Equal and Inclusive Work Environments for Underrepresented Communities
In the past few weeks, equality and inclusivity have been the trending topics on social media, with companies across the globe promoting diversity in their teams and expressing their support for underrepresented communities. Indeed, in light of the worldwide Black Lives Matter movement, plus June b…
June 29, 2020
People of Synthace: Adam Vartanian, Senior Software Engineer
The work I'm doing directly translates into new features in the product
that we go out and try to sell to customers.
June 29, 2020
Here’s Why You Should Stop Doing Science Like You Were Taught in High School: Part 2
Read “Here’s Why You Should Stop Doing Science Like You Were Taught in High School: Part 1”
From One-Factor-At-A-Time to Design of Experiments One-factor-at-a-time (OFAT) methods were widely adopted by scientists to simplify the study of complex systems. One component (factor) is picked at a time a…
June 24, 2020
Advice for Scientists Returning to the Lab
As lockdown restrictions begin to ease across the globe and people return to work, lab scientists will also be returning to their projects and trying to get them back on track as soon as possible. But what challenges or hurdles will scientists initially need to overcome on their return, and are the…
June 17, 2020
Computer-Aided Biology: The Metadata Responsibility
New whitepaper by Synthace highlights the crucial role of metadata in an AI and automation powered lab of the futureLONDON June 17, 2020 - Synthace Ltd, the company behind Antha, the cloud-based software platform for automating and improving the success rate of biological processes, is pleas…
Synthace Frequently Asked Questions
When was Synthace founded?
Synthace was founded in 2011.
Who are Synthace key executives?
Synthace's key executives are Bob Wiederhold, Tim Fell and Christopher Grant Ward.
How many employees does Synthace have?
Synthace has 80 employees.
What is Synthace revenue?
Latest Synthace annual revenue is £581 .
What is Synthace revenue per employee?
Latest Synthace revenue per employee is £7 .
Who are Synthace competitors?
Competitors of Synthace include International Stem Cell Corporation, Transgene and Clementia Pharmaceuticals.
Where is Synthace headquarters?
Synthace headquarters is located at 195 Wood Ln, Shepherd's Bush, London.
Where are Synthace offices?
Synthace has offices in London and Cambridge.
How many offices does Synthace have?
Synthace has 2 offices.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies